Monday, Jun 25, 2018
One of America's Great Newspapers ~ Toledo, Ohio


OK of breast cancer drug may clear way for change in standards

WASHINGTON A drug made by Genentech received federal approval on Friday to treat breast cancer, a decision that could represent a major shift in standards for assessing the effectiveness of cancer medicines.

Going against the recommendation of its advisory panel, the Food and Drug Administration cleared Genentech s Avastin, which is already approved for treating lung and colon cancer, based on findings that it slowed tumor growth.

The agency has traditionally approved drugs for late-stage cancer if they extended, or improved the quality of, patients lives. Avastin showed neither, according to Genentech s application.

Wall Street analysts believe FDA s Avastin decision opens the door for other cancer drugs to be approved for their tumor-shrinking capabilities a trend that worries some health experts.

Read more in later editions of The Blade and

Click to comment

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2018 Toledo Blade

To Top

Fetching stories…